Exploring the Diagnosis and Treatment of Noneosinophilic Chronic Rhinosinusitis (AMW2023)

Exploring the Diagnosis and Treatment of Noneosinophilic Chronic Rhinosinusitis (AMW2023)

PROGRAM DESCRIPTION: Over the past 5 years, chronic rhinosinusitis (CRS) treatment has been revolutionized by the introduction of biologics that target specific pathways of type 2 inflammation. While these type 2 inflammatory pathways are common in CRS, CRS itself is heterogenous syndrome of specific subtypes that share phenotypic features, but differ in underlying patho-etiologic mechanisms. In this panel presentation, we will explore those CRS subtypes that are not driven by type 2 inflammation. These CRS subtypes are often difficult to recognize, and their treatments, while well described in the literature, are not commonly discussed. In short, we will look for options for those patients with non-eosinophilic CRS who are failing initial treatments.Specific CRS subtypes include odontogenic CRS, macrolide-responsive CRS, chronic infection and vasculitis. These CRS subtypes are encountered in the general ENT patient population, but often are diagnosed late. Thus, highlighting these CRS subtypes is important for all ENT physicians who treat nose and sinus conditions.Specific cases will illustrate the relevant diagnostic clues for each condition, and then treatment options will be described. Panelists will discuss pragmatic tips that can be applied at the point-of-care. The case discussion will be supported through focused presentations of the published clinical reports and studies as well as consensus statements. The appropriate work-up, including laboratory testing and imaging, will be described. Innovative diagnostic modalities will be presented. In addition, a framework for approaching these CRS subtypes will be presented.OUTCOME OBJECTIVE 1: Define difficult-to-treat, non-eosinophilic chronic rhinosinusitis (CRS)OUTCOME OBJECTIVE 2: Diagnose CRS subtypes, including odontogenic, macrolide-responsive, vasculitis and infectionOUTCOME OBJECTIVE 3: Select and monitor treatments for these CRS subtypesBACKGROUND STATEMENT: This panel presentation will explore chronic rhinosinusitis (CRS) subtypes that are not driven by type 2 inflammation. These CRS subtypes are difficult to recognize and treat. In short, we will look for options for those patients with non-eosinophilic CRS.

  • Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
  • Activity Link: http://media.mycrowdwisdom.com.s3.amazonaws.com/aao-hnsf/2023_Annual_Meeting_Webcasts/23AMW2409874.mp4
  • Start Date: 2023-10-01 05:00:00
  • End Date: 2023-10-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Rhinology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.